Lynparza ovarian cancer Clinical Experience Investigation (All case investigation)

Trial Identifier:	D0816C00019
Sponsor:	AstraZeneca
NCTID::	NCT03505307
Start Date:	May 2018
Primary Completion Date:	December 2020
Study Completion Date:	December 2020
Condition:	Ovarian Cancer

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

No locations posted.

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.